Outlook Therapeutics, Inc. (OTLK) Net income 2016–2025
Outlook Therapeutics, Inc. (OTLK) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$62.4MFY2025 · since FY2016: -$53.3M → -$62.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$62.4M | +17.2% |
| FY2024 | -$75.4M | -27.8% |
| FY2023 | -$59.0M | +10.7% |
| FY2022 | -$66.1M | -24.2% |
| FY2021 | -$53.2M | -50.9% |
| FY2020 | -$35.2M | -2.1% |
| FY2019 | -$34.5M | -14.7% |
| FY2018 | -$30.1M | +22.5% |
| FY2017 | -$38.8M | +27.1% |
| FY2016 | -$53.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice